Full-service ophthalmic expertise — retina to cornea, device to drug.
At iuvo, we support sponsors at every stage of development, from Phase I first-in-human studies to Phase III pivotal trials and post-market programs. Our experience spans both pharmaceutical and medical device trials, including biologics, gene therapies, and novel ocular implants.
By focusing exclusively on eye research, we’ve built a deep understanding of trial endpoints, patient populations, and the investigative sites that make ophthalmic programs successful. We also collaborate with trusted partners — like reading centers, imaging core labs, and biomarker specialists — to deliver full-service support without the overhead of a generalist CRO.
Whether you’re targeting retina, cornea, glaucoma, or rare ocular diseases, our team has likely walked that path before and knows how to get you there faster.
We don’t just run trials — we help shape them.
iuvo works closely with our Clinical Advisory Board, a hand-selected group of leading ophthalmologists and subspecialists, to strengthen our trial strategies from the very beginning. From bid development and feasibility planning to protocol refinement and site engagement, our advisors provide practical insight that enhances study design and, ultimately, trial execution.
Their involvement ensures that our proposals are not only operationally sound but also clinically relevant and compelling to sites, sponsors, and regulators.
iuvo supports trials for a wide range of treatment types:
Partner with an ophthalmic contract research organization committed to accelerating your clinical trial success.
